Press Releases from Roots Analysis (201 total)
The global cell therapy packaging services market is projected to be worth USD 1 …
With the growing pipeline of cell therapy products as potential treatments options for a myriad of diseases, drug developers are likely to collaborate with players offering packaging and logistics services to ensure safe and timely supply to the patients
London
Roots Analysis has announced the addition of “Cell Therapy Packaging Products and Services Market, 2021-2030”report to its list of offerings.
Currently, more than 30 cell therapies have received marketing approvals across the world,…
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.
Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge…
The opportunity within the display library technologies and services market is p …
Given the various limitations of the conventional drug discovery methods, the innovator companies are increasingly adopting the advanced technologies, such as display-library technologies for rapid and successful screening of novel therapeutics
London
Roots Analysis has announced the addition of “Display Library Technologies and Affiliated Services Market, 2021-2030” report to its list of offerings.
Display libraries have been successfully employed for the generation of various novel therapeutics and offer certain advantages over conventional drug…
The viral and non-viral vector manufacturing market is projected to grow at an a …
The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities to manufacture viral and non-viral gene delivery solutions
London
Roots Analysis has announced the addition of “Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition) 2021 – 2030” report to its list of offerings.
Over time, ~15 cell and gene therapies have been approved across the…
The vascular disrupting agents market is projected to be worth USD 2 billion by …
Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications
London
Roots Analysis has announced the addition of “Vascular Disrupting Agents Market, 2021-2030” report to its list of offerings.
Despite multiple cancer treatment options, there is an evident unmet need for anti-cancer therapies with better efficacy and less toxicity. The vascular disrupting agents, which target the established tumor vasculature and disrupt blood…
The targeted protein degradation enabling technologies market, featuring a healt …
Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare
London
Roots Analysis has announced the addition of “Targeted Protein Degradation Market, 2021-2030” report to its list of offerings.
Small-molecule-induced protein degradation has been demonstrated to possess the potential to drug a broader range of proteinaceous biological targets. It involves the…
The immunocytokines market is estimated to be worth around USD 5.4 billion by 20 …
Advances in molecular biology and tumor immunology have enabled the development of therapeutic fusion proteins, having the ability to activate immunologically cold microenvironments without the safety concerns associated with cytokine therapies
London
Roots Analysis has announced the addition of the “Immunocytokines Market, 2021-2030” report to its list of offerings.
These engineered pharmacologically-active molecules have, so far, demonstrated better efficacy and reduced toxicity compared to conventional cytokine-based therapies. As a result, immunocytokines are…
The antibody purification services market is projected to be worth USD 2.02 bill …
Amidst the COVID-19 pandemic, there has been an evident surge in demand for standard quality antibodies for research, diagnosis and therapeutic purposes, which has presented lucrative opportunities for contract service providers having antibody purification capabilities
London
Roots Analysis has announced the addition of “Global Antibody Purification Services Market, 2021 – 2030” report to its list of offerings.
Isolation and purification of antibodies, from different sources, including serum, ascites fluid and hybridoma…
The cloud-based solutions for drug discovery, development and manufacturing mark …
The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solutions, to not only expedite associated timelines, but also cuts down overall cost
Roots Analysis has announced the addition of “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market by Type of Cloud (Private, Public and Hybrid), Type of Service (Infrastructure as a Service (IaaS), Platform as a Service (PaaS) and Software as a Service…
The cell therapy manufacturing market is projected to reach USD 14.5 billion by …
Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one of the highest valued markets within the biopharmaceutical industry
London
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (4th Edition), 2021-2030” report to its list of offerings.
Owing to the complex manufacturing processes, requirement of advanced production facilities and the growing demand for cell therapy products,…
The biopharmaceutical CROs market is projected to be worth USD 67 billion by 203 …
Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order to remain competitive, flexible, and profitable in the industry
Roots Analysis has announced the addition of “Biopharmaceutical CROs Market, 2021-2030,” report to its list of offerings.
Given their numerous advantages, which include high specificity for intended molecular targets, ability to treat a myriad of disease indications, and…
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predi …
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their proprietary therapy candidates with cautious optimism
Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (3rd Edition), 2019-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapy-market-3rd-edition-2019-2030/268.html
The report features an extensive study of the current market landscape of…
Growing at an annualized rate of 10%, the fragment-based drug discovery market i …
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges
London
Roots Analysis has announced the addition of the “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report to its list of offerings.
According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable…
The oligonucleotide synthesis, modification and purification services market is …
The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing facilities, has generated a range of new opportunities for custom manufacturers
London
Roots Analysis has announced the addition of the “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030” report to its list of offerings.
In fact, several big pharma companies are known to outsource more…
The opportunity for AR / VR based digital marketing service providers in healthc …
Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies
Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html
Over time, various pharma players have taken advantage of these immersive technologies for education, training as well…
The antibody drug conjugates market is estimated to be worth more than 15 billio …
Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of…
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predi …
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their proprietary therapy candidates with cautious optimism
Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (3rd Edition), 2019-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapy-market-3rd-edition-2019-2030/268.html
The report features an extensive study of the current market landscape of…
The drug repurposing service providers market is estimated to be worth USD 1.2 b …
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”
For more information please click on the following
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
The report features an extensive study of the current market landscape and…
The global autoinjectors market is projected to grow at an annualized rate of ov …
Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Autoinjectors Market (3rd Edition), 2020-2030.”
For more information please click on the following
https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html
The report features an extensive study of the current market landscape, offering an informed opinion…
Growing at an annualized rate of over 16.5%, the cell therapy manufacturing mark …
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.
For additional details, please visit - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Owing to various reasons, the demand for cell therapies is…
With over 280 therapies under evaluation, the stem cell therapy market is estima …
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical Therapies,…
The subcutaneous biologic drugs and affiliated technologies market is projected …
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals
Roots Analysis is pleased to announce the publication of its recent study, titled “Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
The report provides…
The STING pathway targeting technologies market, featuring a healthy pipeline of …
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
The report features an extensive study of the current market landscape and…
The contract manufacturing market for Pharmaceuticals in China is estimated to b …
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world
Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”
For more information please click on the following
https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html
The report features an extensive study of the current market…
The Chinese biopharmaceutical contract manufacturing market is estimated to be w …
The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years
Roots Analysis is pleased to announce the publication of its recent study, titled, “China Biopharmaceutical Contract Manufacturing Market, 2020-2030.”
The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of…
Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.
Owing to various reasons, the demand for cell therapies is anticipated to increase over the…
Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.
To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this…
Cell and Advanced Therapies Supply Chain Management Market, 2020-2030
The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.
To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this -
https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
The USD 1.5…
The Companion Diagnostics Development Services Market is estimated to be worth o …
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise
Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030”
For more information please click on the following
https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
The report features an extensive study of the…
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth US …
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”
For more information please click on the following https://www.rootsanalysis.com/reports/253/request-sample.html:
https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
The report features an extensive…
The RNAi therapeutics market is anticipated to grow at an annualized rate of mor …
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research
London
Roots Analysis has announced the addition of “RNAi Therapeutics Market (2nd Edition), 2019-2030” report to its list of offerings.
Significant advancements in the developmental pipeline across various oncological disorders, infectious diseases and genetic disorders have amplified the interest of various pharmaceutical establishments and have…
The subcutaneous biologic drugs and affiliated technologies market is projected …
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals
Roots Analysis is pleased to announce the publication of its recent study, titled “Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
The report provides…
The STING pathway targeting technologies market, featuring a healthy pipeline of …
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
The report features an extensive study of the current market landscape and…
The targeted protein degradation market is projected to grow at an annualized ra …
The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to…
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by …
In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, the US FDA routinely uses real world evidence to monitor post market safety of drugs
Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of offerings.
The digitization of data and advances in information processing, have…
The synthetic lethality-based drugs and targets market is estimated to be worth …
Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
The …
The antibody contract manufacturing market is projected to reach USD 17 billion …
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email sales@rootsanalysis.com
Although biopharmaceuticals offer significant profit margins and have been proven to…
The fragment-based drug discovery market is estimated to be worth around USD 1.6 …
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery
Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.”
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html
The report features an extensive…
The global digital biomarkers market is projected to be worth over USD 22 billio …
Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pertinent applications, are being increasingly adopted in modern healthcare practices
Roots Analysis has announced the addition of “Digital Solutions for Biomarkers Market, 2021-2030” report to its list of offerings.
Digital solutions for biomarkers are modern solutions that are capable of generating, collecting, and tracking medical data. From this data, digital…
The endocannabinoid system targeted therapeutics market is projected to be over …
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions
London
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.
Over time, extensive R&D on the potential health benefits of cannabis, have…
The oligonucleotide synthesis, modification and purification services market is …
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.”
For more information please click on the following…
The nuclear medicine and radiopharmaceutical manufacturing market is estimated t …
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals
Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
The report provides a detailed study on the current market landscape…
The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, g …
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential
Roots Analysis is pleased to announce the publication of its recent study, titled, “Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
The report features a comprehensive study of the current scenario and future potential…
The proteome profiling services market is projected to be worth USD 16 billion b …
Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise
Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/proteome-profiling-services.html
The report features an extensive study of the current market landscape…
The global preventive vaccines market is projected to be worth USD 94 billion by …
Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2020-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
The report features an extensive study of the current market landscape…
The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, …
Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency of regulatory review, causing sponsors to rely on the technical and regulatory affairs management expertise of CROs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CRO Market (2nd Edition), 2020-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html
The report features an…
The next generation contact lenses and visual prostheses market is estimated to …
Recent technological advances in the field of ophthalmology and the availability of new biomaterials have substantially expanded the range of potential application areas of contact lenses and enabled the development of novel prosthetic products
Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/next-generation-contact-lenses-and-visual-prostheses-market-2019-2030/244.html
The report features an extensive study of…
Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, g …
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential
London
Roots Analysis has announced the addition of “Neoantigen Targeted Therapies, 2019-2030” report to its list of offerings.
The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are…
The contract fill / finish services market for biologics is anticipated to be wo …
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
The report features an extensive study on the contract service providers…
Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract man …
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers
Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html
The report features an extensive study of the current market landscape and future opportunities associated with the contract…
